Indonesia
· Delayed Price · Currency is IDR IDX:MEDC Statistics
Total Valuation
IDX:MEDC has a market cap or net worth of IDR 32.00 trillion. The enterprise value is 81.12 trillion.
| Market Cap | 32.00T |
| Enterprise Value | 81.12T |
Important Dates
The next estimated earnings date is Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
IDX:MEDC has 25.00 billion shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 25.00B |
| Shares Outstanding | 25.00B |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | 1.50% |
| Owned by Institutions (%) | 3.47% |
| Float | 6.25B |
Valuation Ratios
The trailing PE ratio is 6.18 and the forward PE ratio is 7.69.
| PE Ratio | 6.18 |
| Forward PE | 7.69 |
| PS Ratio | 0.82 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 2.32 |
| P/OCF Ratio | 1.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.56, with an EV/FCF ratio of 5.88.
| EV / Earnings | 15.69 |
| EV / Sales | 2.08 |
| EV / EBITDA | 3.56 |
| EV / EBIT | 6.83 |
| EV / FCF | 5.88 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.57.
| Current Ratio | 1.37 |
| Quick Ratio | 1.12 |
| Debt / Equity | 1.57 |
| Debt / EBITDA | 2.82 |
| Debt / FCF | 4.41 |
| Interest Coverage | 2.06 |
Financial Efficiency
Return on equity (ROE) is 14.50% and return on invested capital (ROIC) is 6.95%.
| Return on Equity (ROE) | 14.50% |
| Return on Assets (ROA) | 5.17% |
| Return on Invested Capital (ROIC) | 6.95% |
| Return on Capital Employed (ROCE) | 9.86% |
| Revenue Per Employee | 11.71B |
| Profits Per Employee | 1.55B |
| Employee Count | 3,327 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 6.57 |
Taxes
In the past 12 months, IDX:MEDC has paid 4.80 trillion in taxes.
| Income Tax | 4.80T |
| Effective Tax Rate | 47.33% |
Stock Price Statistics
The stock price has increased by +7.39% in the last 52 weeks. The beta is 0.79, so IDX:MEDC's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +7.39% |
| 50-Day Moving Average | 1,103.20 |
| 200-Day Moving Average | 1,159.10 |
| Relative Strength Index (RSI) | 79.69 |
| Average Volume (20 Days) | 54,390,200 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:MEDC had revenue of IDR 38.98 trillion and earned 5.17 trillion in profits. Earnings per share was 206.51.
| Revenue | 38.98T |
| Gross Profit | 23.74T |
| Operating Income | 10.72T |
| Pretax Income | 10.14T |
| Net Income | 5.17T |
| EBITDA | 19.34T |
| EBIT | 10.72T |
| Earnings Per Share (EPS) | 206.51 |
Balance Sheet
The company has 15.60 trillion in cash and 60.89 trillion in debt, giving a net cash position of -45,291.52 billion or -1,811.84 per share.
| Cash & Cash Equivalents | 15.60T |
| Total Debt | 60.89T |
| Net Cash | -45,291.52B |
| Net Cash Per Share | -1,811.84 |
| Equity (Book Value) | 38.74T |
| Book Value Per Share | 1,396.32 |
| Working Capital | 9.25T |
Cash Flow
In the last 12 months, operating cash flow was 20.21 trillion and capital expenditures -6,405.96 billion, giving a free cash flow of 13.80 trillion.
| Operating Cash Flow | 20.21T |
| Capital Expenditures | -6,405.96B |
| Free Cash Flow | 13.80T |
| FCF Per Share | 552.24 |
Margins
Gross margin is 60.89%, with operating and profit margins of 27.50% and 13.27%.
| Gross Margin | 60.89% |
| Operating Margin | 27.50% |
| Pretax Margin | 26.02% |
| Profit Margin | 13.27% |
| EBITDA Margin | 49.60% |
| EBIT Margin | 27.50% |
| FCF Margin | 35.41% |
Dividends & Yields
This stock pays an annual dividend of 45.07, which amounts to a dividend yield of 3.52%.
| Dividend Per Share | 45.07 |
| Dividend Yield | 3.52% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 22.49% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 3.51% |
| Earnings Yield | 16.16% |
| FCF Yield | 43.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 11, 2017. It was a forward split with a ratio of 4.
| Last Split Date | Sep 11, 2017 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
IDX:MEDC has an Altman Z-Score of 1.11 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.11 |
| Piotroski F-Score | 5 |